375 related articles for article (PubMed ID: 8670868)
1. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells.
Nakajima K; Yamanaka Y; Nakae K; Kojima H; Ichiba M; Kiuchi N; Kitaoka T; Fukada T; Hibi M; Hirano T
EMBO J; 1996 Jul; 15(14):3651-8. PubMed ID: 8670868
[TBL] [Abstract][Full Text] [Related]
2. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation.
Yamanaka Y; Nakajima K; Fukada T; Hibi M; Hirano T
EMBO J; 1996 Apr; 15(7):1557-65. PubMed ID: 8612579
[TBL] [Abstract][Full Text] [Related]
3. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
Hirano T; Ishihara K; Hibi M
Oncogene; 2000 May; 19(21):2548-56. PubMed ID: 10851053
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
5. Association of Stat3-dependent transcriptional activation of p19INK4D with IL-6-induced growth arrest.
Narimatsu M; Nakajima K; Ichiba M; Hirano T
Biochem Biophys Res Commun; 1997 Sep; 238(3):764-8. PubMed ID: 9325164
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
[TBL] [Abstract][Full Text] [Related]
7. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
8. STAT3 is dispensable for maintenance of self-renewal in nonhuman primate embryonic stem cells.
Sumi T; Fujimoto Y; Nakatsuji N; Suemori H
Stem Cells; 2004; 22(5):861-72. PubMed ID: 15342949
[TBL] [Abstract][Full Text] [Related]
9. Structure and function of a new STAT-induced STAT inhibitor.
Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
[TBL] [Abstract][Full Text] [Related]
10. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways.
O'Farrell AM; Liu Y; Moore KW; Mui AL
EMBO J; 1998 Feb; 17(4):1006-18. PubMed ID: 9463379
[TBL] [Abstract][Full Text] [Related]
11. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the roles of STAT1 and STAT3 signal transduction pathways in mammalian lens development.
Ebong S; Chepelinsky AB; Robinson ML; Zhao H; Yu CR; Egwuagu CE
Mol Vis; 2004 Feb; 10():122-31. PubMed ID: 14978477
[TBL] [Abstract][Full Text] [Related]
13. B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells.
Bies J; Hoffman B; Amanullah A; Giese T; Wolff L
Oncogene; 1996 Jan; 12(2):355-63. PubMed ID: 8570212
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation.
Murakami-Mori K; Mori S; Taga T; Kishimoto T; Nakamura S
J Immunol; 1997 Jun; 158(11):5518-26. PubMed ID: 9164976
[TBL] [Abstract][Full Text] [Related]
15. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line.
Minami M; Inoue M; Wei S; Takeda K; Matsumoto M; Kishimoto T; Akira S
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3963-6. PubMed ID: 8632998
[TBL] [Abstract][Full Text] [Related]
16. STAT3 exerts two-way regulation in the biological effects of IL-6 in M1 leukemia cells.
Zhang J; Shen B; Li Y; Sun Y
Leuk Res; 2001 Jun; 25(6):463-72. PubMed ID: 11337018
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6 induces DNA binding activity of AP1 in M1 myeloblastic cells but not in a growth resistant cell derivative.
Melamed D; Resnitzky D; Haimov I; Levy N; Pfarr CM; Yaniv M; Kimchi A
Cell Growth Differ; 1993 Aug; 4(8):689-97. PubMed ID: 8398910
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition and augmentation of mouse myeloid leukemic cell line differentiation by interleukin 1.
Onozaki K; Tamatani T; Hashimoto T; Matsushima K
Cancer Res; 1987 May; 47(9):2397-402. PubMed ID: 3494508
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of the effect of forced activation of STAT3 on M1 mouse leukemia cells.
Yoshida T; Iwamoto T; Adachi K; Yokota T; Miyake Y; Hamaguchi M
Int J Mol Med; 2005 Feb; 15(2):269-75. PubMed ID: 15647843
[TBL] [Abstract][Full Text] [Related]
20. MyD genes in negative growth control.
Liebermann DA; Hoffman B
Oncogene; 1998 Dec; 17(25):3319-29. PubMed ID: 9916994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
